Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 9389784, 19 pages
https://doi.org/10.1155/2018/9389784
Research Article

Cardiac Autonomic Neuropathy as a Result of Mild Hypercaloric Challenge in Absence of Signs of Diabetes: Modulation by Antidiabetic Drugs

1Department of Pharmacology and Toxicology, Faculty of Medicine, The American University of Beirut, Beirut, Lebanon
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt

Correspondence should be addressed to Fouad A. Zouein; bl.ude.bua@51zf and Ahmed F. El-Yazbi; bl.ude.bua@88ea

Received 2 October 2017; Revised 21 November 2017; Accepted 29 November 2017; Published 31 January 2018

Academic Editor: Mohamed A. Abdelmegeed

Copyright © 2018 Ola Al-Assi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 28, Supplement 1, pp. S37–S42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization, Global Report on Diabetes, WHO Press, Geneva, Switzerland, 2014.
  3. H. V. Kuhnlein and O. Receveur, “Dietary change and traditional food systems of indigenous peoples,” Annual Review of Nutrition, vol. 16, no. 1, pp. 417–442, 1996. View at Publisher · View at Google Scholar
  4. S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso, “Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,” The New England Journal of Medicine, vol. 339, no. 4, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Giráldez-García, F. Javier Sangrós, A. Díaz-Redondo et al., “Cardiometabolic risk profiles in patients with impaired fasting glucose and/or hemoglobin A1c 5.7% to 6.4%: evidence for a gradient according to diagnostic criteria: the PREDAPS study,” Medicine, vol. 94, no. 44, article e1935, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Huang, X. Cai, W. Mai, M. Li, and Y. Hu, “Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis,” BMJ, vol. 355, article i5953, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. G. de Moura-Tonello, A. Porta, A. Marchi et al., “Cardiovascular variability analysis and baroreflex estimation in patients with type 2 diabetes in absence of any manifest neuropathy,” PLoS One, vol. 11, no. 3, article e0148903, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Svacinova, N. Honzikova, A. Krticka, I. Tonhajzerova, K. Javorka, and M. Javorka, “Diagnostic significance of a mild decrease of baroreflex sensitivity with respect to heart rate in type 1 diabetes mellitus,” Physiological Research, vol. 62, no. 6, pp. 605–613, 2013. View at Google Scholar
  10. A. I. Vinik, T. Erbas, and C. M. Casellini, “Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease,” Journal of Diabetes Investigation, vol. 4, no. 1, pp. 4–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Ziegler, K. Dannehl, H. Muhlen, M. Spuler, and F. A. Gries, “Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy,” Diabetic Medicine, vol. 9, no. 9, pp. 806–814, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Chyun, F. J. T. Wackers, S. E. Inzucchi et al., “Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study,” SAGE Open Medicine, vol. 3, 2015. View at Publisher · View at Google Scholar
  13. A. Q. Green, S. Krishnan, F. M. Finucane, and G. Rayman, “Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance,” Diabetes Care, vol. 33, no. 1, pp. 174–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Freeman, “Diabetic autonomic neuropathy,” Handbook of Clinical Neurology, vol. 126, pp. 63–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. “The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT),” Diabetologia, vol. 41, no. 4, pp. 416–423, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. S. P. Marso, G. H. Daniels, K. Brown-Frandsen et al., “Liraglutide and cardiovascular outcomes in type 2 diabetes,” The New England Journal of Medicine, vol. 375, no. 4, pp. 311–322, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Zinman, C. Wanner, J. M. Lachin et al., “Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes,” The New England Journal of Medicine, vol. 373, no. 22, pp. 2117–2128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. W. N. Kernan, C. M. Viscoli, K. L. Furie et al., “Pioglitazone after ischemic stroke or transient ischemic attack,” The New England Journal of Medicine, vol. 374, no. 14, pp. 1321–1331, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. Diabetes Prevention Program Research Group, “Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study,” The Lancet Diabetes and Endocrinology, vol. 3, pp. 866–875, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. El-Yazbi, M. El-Khatib, M. Fouda, F. Sleiman, E. Saad, H. Fouad et al., “High-calorie diet induces vascular and hemodynamic abnormalities in absence of change in blood glucose or insulin levels: modulation by oral anti-hyperglycemic drugs,” The FASEB Journal, vol. 31, p. 1068.3, 2017. View at Google Scholar
  21. T. Maric, B. Woodside, and G. N. Luheshi, “The effects of dietary saturated fat on basal hypothalamic neuroinflammation in rats,” Brain, Behavior, and Immunity, vol. 36, pp. 35–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Milanski, G. Degasperi, A. Coope et al., “Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity,” The Journal of Neuroscience, vol. 29, no. 2, pp. 359–370, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Saisho, “Metformin and inflammation: its potential beyond glucose-lowering effect,” Endocrine, Metabolic & Immune Disorders-Drug Targets, vol. 15, no. 3, pp. 196–205, 2015. View at Publisher · View at Google Scholar
  24. R. Nerla, D. Pitocco, F. Zaccardi et al., “Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes,” Acta Diabetologica, vol. 47, Supplement 1, pp. 117–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Negrotto, M. F. Farez, and J. Correale, “Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis,” JAMA Neurology, vol. 73, no. 5, pp. 520–528, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. O. O. Rowaiye, E. A. Jankowska, and B. Ponikowska, “Baroreceptor sensitivity and diabetes mellitus,” Cardiology Journal, vol. 20, no. 5, pp. 453–463, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. P. G. Reeves, F. H. Nielsen, and G. C. Fahey Jr., “AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet,” The Journal of Nutrition, vol. 123, no. 11, pp. 1939–1951, 1993. View at Google Scholar
  28. Y. Wang, S. E. Thatcher, and L. A. Cassis, “Measuring blood pressure using a noninvasive tail cuff method in mice,” Methods in Molecular Biology, vol. 1614, pp. 69–73, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Hanton, V. Eder, G. Rochefort, P. Bonnet, and J. M. Hyvelin, “Echocardiography, a non-invasive method for the assessment of cardiac function and morphology in preclinical drug toxicology and safety pharmacology,” Expert Opinion on Drug Metabolism & Toxicology, vol. 4, no. 6, pp. 681–696, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Lozano, R. Van der Werf, W. Bietiger et al., “High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications,” Nutrition & Metabolism, vol. 13, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Ghali-Ghoul, R. Tahseldar-Roumieh, and R. Sabra, “Effect of chronic administration of sildenafil on sodium retention and on the hemodynamic complications associated with liver cirrhosis in the rat,” European Journal of Pharmacology, vol. 572, no. 1, pp. 49–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. H. M. El-Gowelli, K. S. Ibrahim, A. F. El-Yazbi, and M. M. El-Mas, “Role of NADPHox/Rho-kinase signaling in the cyclosporine-NSAIDs interactions on blood pressure and baroreflexes in female rats,” Life Sciences, vol. 185, pp. 15–22, 2017. View at Publisher · View at Google Scholar
  33. A. F. El-Yazbi, K. S. Ibrahim, H. M. El-Gowelli, N. M. El-Deeb, and M. M. El-Mas, “Modulation by NADPH oxidase of the chronic cardiovascular and autonomic interaction between cyclosporine and NSAIDs in female rats,” European Journal of Pharmacology, vol. 806, pp. 96–104, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. A. G. Omar and M. M. El-Mas, “Time-domain evaluation of cyclosporine interaction with hemodynamic variability in rats,” Cardiovascular Drugs and Therapy, vol. 18, no. 6, pp. 461–468, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. M. El-Mas and A. A. Abdel-Rahman, “Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats,” Life Sciences, vol. 76, no. 8, pp. 901–915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. K. Stein, M. S. Bosner, R. E. Kleiger, and B. M. Conger, “Heart rate variability: a measure of cardiac autonomic tone,” American Heart Journal, vol. 127, no. 5, pp. 1376–1381, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Tronel, G. Y. Rochefort, N. Arlicot, S. Bodard, S. Chalon, and D. Antier, “Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 264935, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. F. El-Yazbi, R. P. Johnson, E. J. Walsh, K. Takeya, M. P. Walsh, and W. C. Cole, “Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries,” The Journal of Physiology, vol. 588, no. 10, pp. 1747–1762, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. F. El-Yazbi, K. S. Abd-Elrahman, and A. Moreno-Dominguez, “PKC-mediated cerebral vasoconstriction: role of myosin light chain phosphorylation versus actin cytoskeleton reorganization,” Biochemical Pharmacology, vol. 95, no. 4, pp. 263–278, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Moreno-Domínguez, A. F. El-Yazbi, H.-L. Zhu et al., “Cytoskeletal reorganization evoked by Rho-associated kinase- and protein kinase C-catalyzed phosphorylation of cofilin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries,” Journal of Biological Chemistry, vol. 289, no. 30, pp. 20939–20952, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Z. Zhong, K. S. Abd-Elrahman, C. H. Liao et al., “Stromatoxin-sensitive, heteromultimeric Kv2.1/Kv9.3 channels contribute to myogenic control of cerebral arterial diameter,” The Journal of Physiology, vol. 588, no. 22, pp. 4519–4537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Y. Liu, F. C. Liu, C. Y. Deng et al., “Left ventricular deformation associated with cardiomyocyte Ca2+ transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats,” BMC Cardiovascular Disorders, vol. 16, no. 1, p. 41, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. D. B. Ballak, R. Stienstra, C. J. Tack, C. A. Dinarello, and J. A. van Diepen, “IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance,” Cytokine, vol. 75, no. 2, pp. 280–290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. E. Kang, J. M. Kim, K. H. Joung et al., “The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction,” PLoS One, vol. 11, no. 4, article e0154003, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Allen, L. Ramalingam, K. Menikdiwela et al., “Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice,” The Journal of Nutritional Biochemistry, vol. 48, pp. 128–137, 2017. View at Publisher · View at Google Scholar
  46. K. A. Posey, D. J. Clegg, R. L. Printz et al., “Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet,” American Journal of Physiology - Endocrinology and Metabolism, vol. 296, no. 5, pp. E1003–E1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Sousa-Pinto, L. Gonçalves, A. R. Rodrigues et al., “Characterization of TGF-β expression and signaling profile in the adipose tissue of rats fed with high-fat and energy-restricted diets,” The Journal of Nutritional Biochemistry, vol. 38, pp. 107–115, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. A. B. Evert, J. L. Boucher, M. Cypress et al., “Nutrition therapy recommendations for the management of adults with diabetes,” Diabetes Care, vol. 36, no. 11, pp. 3821–3842, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Buettner, J. Scholmerich, and L. C. Bollheimer, “High-fat diets: modeling the metabolic disorders of human obesity in rodents,” Obesity, vol. 15, no. 4, pp. 798–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Valensi, “Hypertension, single sugars and fatty acids,” Journal of Human Hypertension, vol. 19, no. S3, pp. S5–S9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S. S. Elliott, N. L. Keim, J. S. Stern, K. Teff, and P. J. Havel, “Fructose, weight gain, and the insulin resistance syndrome,” The American Journal of Clinical Nutrition, vol. 76, no. 5, pp. 911–922, 2002. View at Google Scholar
  52. W. C. Dornas, W. G. de Lima, M. L. Pedrosa, and M. E. Silva, “Health implications of high-fructose intake and current research,” Advances in Nutrition: An International Review Journal, vol. 6, no. 6, pp. 729–737, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Z. Toklu, J. Muller-Delp, Y. Sakaraya et al., “High dietary fructose does not exacerbate the detrimental consequences of high fat diet on basilar artery function,” Journal of Physiology and Pharmacology, vol. 67, no. 2, pp. 205–216, 2016. View at Google Scholar
  54. H. A. Peredo, H. Lee, A. S. Donoso, V. Andrade, N. Sanchez Eluchans, and A. M. Puyo, “A high-fat plus fructose diet produces a vascular prostanoid alterations in the rat,” Autonomic & Autacoid Pharmacology, vol. 34, no. 3-4, pp. 35–40, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. J.-P. Huang, M.-L. Cheng, C.-Y. Hung et al., “Docosapentaenoic acid and docosahexaenoic acid are positively associated with insulin sensitivity in rats fed high-fat and high-fructose diets,” Journal of Diabetes, vol. 9, no. 10, pp. 936–946, 2017. View at Publisher · View at Google Scholar · View at Scopus
  56. J. I. Kim, “High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17,” The Korean Journal of Physiology & Pharmacology, vol. 21, no. 1, pp. 99–106, 2017. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Ghatta and P. Ramarao, “Increased contractile responses to 5-hydroxytryptamine and angiotensin II in high fat diet fed rat thoracic aorta,” Lipids in Health and Disease, vol. 3, no. 1, p. 19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Kudat, V. Akkaya, A. B. Sozen et al., “Heart rate variability in diabetes patients,” Journal of International Medical Research, vol. 34, no. 3, pp. 291–296, 2006. View at Publisher · View at Google Scholar
  59. E. B. Schroeder, L. E. Chambless, D. Liao et al., “Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study,” Diabetes Care, vol. 28, no. 3, pp. 668–674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. A. S. Balcıoğlu, S. Akıncı, D. Çiçek, A. Çoner, U. A. Bal, and İ. H. Müderrisoğlu, “Cardiac autonomic nervous dysfunction detected by both heart rate variability and heart rate turbulence in prediabetic patients with isolated impaired fasting glucose,” The Anatolian Journal of Cardiology, vol. 16, no. 10, pp. 762–769, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Koskinen, M. Kähönen, A. Jula et al., “Metabolic syndrome and short-term heart rate variability in young adults,” Diabetic Medicine, vol. 26, no. 4, pp. 354–361, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. V. Soetikno, F. R. Sari, V. Sukumaran et al., “Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC–MAPK signaling pathway,” European Journal of Pharmaceutical Sciences, vol. 47, no. 3, pp. 604–614, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Sa-nguanmoo, P. Tanajak, S. Kerdphoo et al., “SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats,” Toxicology and Applied Pharmacology, vol. 333, pp. 43–50, 2017. View at Publisher · View at Google Scholar
  64. J. C. Cruz, A. F. L. Flôr, M. S. França-Silva, C. M. Balarini, and V. A. Braga, “Reactive oxygen species in the paraventricular nucleus of the hypothalamus alter sympathetic activity during metabolic syndrome,” Frontiers in Physiology, vol. 6, p. 384, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. A. J. Scheen, N. Esser, and N. Paquot, “Antidiabetic agents: potential anti-inflammatory activity beyond glucose control,” Diabetes & Metabolism, vol. 41, no. 3, pp. 183–194, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. P. King, I. Peacock, and R. Donnelly, “The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes,” British Journal of Clinical Pharmacology, vol. 48, no. 5, pp. 643–648, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Lee, J. L. Saver, H. W. Liao, C. H. Lin, and B. Ovbiagele, “Pioglitazone for secondary stroke prevention: a systematic review and meta-analysis,” Stroke, vol. 48, no. 2, pp. 388–393, 2017. View at Publisher · View at Google Scholar · View at Scopus
  68. A. R. Cameron, V. L. Morrison, D. Levin et al., “Anti-inflammatory effects of metformin irrespective of diabetes status,” Circulation Research, vol. 119, no. 5, pp. 652–665, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. Q.-L. Mao-Ying, A. Kavelaars, K. Krukowski et al., “The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model,” PLoS One, vol. 9, no. 6, article e100701, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Kapadia, J. H. Yi, and R. Vemuganti, “Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists,” Frontiers in Bioscience, vol. 13, no. 13, pp. 1813–1826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Dong, Y. Zhang, L. Yang, G. Liu, J. Ye, and H. Wang, “Effects of a high-fat diet on adipose tissue CD8+ T cells in young vs. adult mice,” Inflammation, vol. 40, no. 6, pp. 1944–1958, 2017. View at Publisher · View at Google Scholar
  72. M. Spencer, L. Yang, A. Adu et al., “Pioglitazone treatment reduces adipose tissue inflammation through reduction of mast cell and macrophage number and by improving vascularity,” PLoS One, vol. 9, no. 7, article e102190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Qi, Y. Chen, H. Li et al., “A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses,” Journal of Molecular Endocrinology, vol. 59, no. 1, pp. 49–59, 2017. View at Publisher · View at Google Scholar
  74. A. B. Nair and S. Jacob, “A simple practice guide for dose conversion between animals and human,” Journal of Basic and Clinical Pharmacy, vol. 7, no. 2, pp. 27–31, 2016. View at Publisher · View at Google Scholar
  75. D. Manzella, R. Grella, K. Esposito, D. Giugliano, M. Barbagallo, and G. Paolisso, “Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration,” American Journal of Hypertension, vol. 17, no. 3, pp. 223–227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. F. E. Gianiorio, M. Casu, V. Patrone, C. G. Egan, and G. Murialdo, “Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes,” Acta Diabetologica, vol. 48, no. 4, pp. 283–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. S. P. Loewen, A. R. Paterson, S. Y. Loh et al., “Sex-specific differences in cardiovascular and metabolic hormones with integrated signalling in the paraventricular nucleus of the hypothalamus,” Experimental Physiology, vol. 102, no. 11, pp. 1373–1379, 2017. View at Publisher · View at Google Scholar
  78. K. Labuzek, D. Suchy, B. Gabryel, A. Bielecka, S. Liber, and B. Okopien, “Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide,” Pharmacological Reports, vol. 62, no. 5, pp. 956–965, 2010. View at Publisher · View at Google Scholar
  79. W. T. Festuccia, S. Oztezcan, M. Laplante et al., “Peroxisome proliferator-activated receptor-γ-mediated positive energy balance in the rat is associated with reduced sympathetic drive to adipose tissues and thyroid status,” Endocrinology, vol. 149, no. 5, pp. 2121–2130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. O. A. Obeid, “Low phosphorus status might contribute to the onset of obesity,” Obesity Reviews, vol. 14, no. 8, pp. 659–664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. S. A. Gibson, “Dietary sugars intake and micronutrient adequacy: a systematic review of the evidence,” Nutrition Research Reviews, vol. 20, no. 2, pp. 121–131, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. J. J. Ayoub, M. J. A. Samra, S. A. Hlais, M. S. Bassil, and O. A. Obeid, “Effect of phosphorus supplementation on weight gain and waist circumference of overweight/obese adults: a randomized clinical trial,” Nutrition & Diabetes, vol. 5, no. 12, article e189, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Bassil and O. Obeid, “Phosphorus supplementation recovers the blunted diet-induced thermogenesis of overweight and obese adults: a pilot study,” Nutrients, vol. 8, no. 12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Hazim, S. Hlais, H. Ghattas, D. Shatila, M. Bassil, and O. Obeid, “Phosphorus supplement alters postprandial lipemia of healthy male subjects: a pilot cross-over trial,” Lipids in Health and Disease, vol. 13, no. 1, p. 109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Khattab, C. Abi-Rashed, H. Ghattas, S. Hlais, and O. Obeid, “Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: a crossover experiment,” Nutrition Journal, vol. 14, no. 1, p. 112, 2015. View at Publisher · View at Google Scholar · View at Scopus